Get the Stockscreener App
1.26
0.00%
0.00
After Hours:
1.24
-0.02
-1.59%
Evogene Ltd stock is traded at $1.26, with a volume of 33,650.
It is up +0.00% in the last 24 hours and up +9.57% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
See More
Previous Close:
$1.26
Open:
$1.26
24h Volume:
33,650
Relative Volume:
0.41
Market Cap:
$10.98M
Revenue:
$6.74M
Net Income/Loss:
$-14.74M
P/E Ratio:
-0.5602
EPS:
-2.2491
Net Cash Flow:
$-18.31M
1W Performance:
-0.79%
1M Performance:
+9.57%
6M Performance:
+6.78%
1Y Performance:
-43.75%
1-Day Range:
$1.25
$1.27
1-Week Range:
$1.20
$1.33
52-Week Range:
$0.95
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.26 | 10.98M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
How strong is Evogene Ltd. stock revenue growth2025 Big Picture & Safe Entry Zone Identification - newser.com
Technical analysis overview for Evogene Ltd. stockPortfolio Return Report & Accurate Buy Signal Notifications - newser.com
Real time social sentiment graph for Evogene Ltd.Market Performance Report & Free Long-Term Investment Growth Plans - newser.com
Relative strength of Evogene Ltd. in sector analysisWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
How to forecast Evogene Ltd. trends using time seriesWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
What does recent volatility data suggest for Evogene Ltd.Portfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Evogene Ltd. stock prediction for this weekPortfolio Value Summary & Risk Managed Investment Signals - newser.com
Is Evogene Ltd. stock attractive for retirement portfoliosJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Will Evogene Ltd. stock gain from strong economyMarket Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Candlestick signals on Evogene Ltd. stock todayJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
What earnings revisions data tells us about Evogene Ltd.Weekly Gains Report & Accurate Intraday Trade Tips - newser.com
How to monitor Evogene Ltd. with trend dashboardsBull Run & Weekly Top Gainers Trade List - newser.com
Using Python tools to backtest Evogene Ltd. strategiesJuly 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Is Evogene Ltd. stock a defensive play in 2025July 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
What technical models suggest about Evogene Ltd.’s comebackGold Moves & AI Driven Stock Movement Reports - newser.com
Is Evogene Ltd. forming a reversal pattern2025 Risk Factors & Growth Focused Investment Plans - newser.com
Institutional scanner results for Evogene Ltd.Weekly Gains Summary & Safe Entry Point Identification - newser.com
Can Evogene Ltd. stock withstand economic slowdownQuarterly Risk Review & Technical Entry and Exit Tips - newser.com
Custom strategy builders for tracking Evogene Ltd.July 2025 Action & Weekly High Potential Alerts - newser.com
How to manage a losing position in Evogene Ltd.Quarterly Growth Report & Technical Buy Zone Confirmations - newser.com
How Evogene Ltd. stock benefits from tech adoptionJuly 2025 Setups & High Accuracy Investment Signals - newser.com
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):